| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 181 |
| 1 | INFLIXIMAB | 92 |
| 2 | ADALIMUMAB-ADAZ | 72 |
| 3 | PREDNISONE | 66 |
| 4 | ADALIMUMAB-AATY | 60 |
| 5 | ADALIMUMAB-FKJP | 60 |
| 6 | VEDOLIZUMAB | 51 |
| 7 | AZATHIOPRINE | 49 |
| 8 | USTEKINUMAB | 48 |
| 9 | METHOTREXATE SODIUM | 42 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | USTEKINUMAB-AUUB | 2 | 0.0114 |
| 1 | INFLIXIMAB-DYYB | 28 | 0.0081 |
| 2 | PENCICLOVIR | 1 | 0.0028 |
| 3 | USTEKINUMAB-STBA | 1 | 0.0027 |
| 4 | ADALIMUMAB-RYVK | 2 | 0.0018 |
| 5 | INFLIXIMAB-AXXQ | 2 | 0.0017 |
| 6 | ADALIMUMAB-ADAZ | 72 | 0.0013 |
| 7 | ADALIMUMAB-FKJP | 60 | 0.0013 |
| 8 | MESALAMINE | 35 | 0.0012 |
| 9 | ADALIMUMAB-AATY | 60 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 148 |
| 1 | Corticosteroid [EPC] | 96 |
| 2 | Integrin Receptor Antagonist [EPC] | 51 |
| 3 | Interleukin-12 Antagonist [EPC] | 51 |
| 4 | Interleukin-23 Antagonist [EPC] | 51 |
| 5 | Purine Antimetabolite [EPC] | 49 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 38 |
| 7 | Aminosalicylate [EPC] | 31 |
| 8 | Janus Kinase Inhibitor [EPC] | 30 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 51 | 0.0006 |
| 1 | Purine Antimetabolite [EPC] | 49 | 0.0005 |
| 2 | Interleukin-12 Antagonist [EPC] | 51 | 0.0005 |
| 3 | Interleukin-23 Antagonist [EPC] | 51 | 0.0005 |
| 4 | Aminosalicylate [EPC] | 31 | 0.0003 |
| 5 | Janus Kinase Inhibitor [EPC] | 30 | 0.0002 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 148 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 38 | 0.0001 |
| 9 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |